Review Article Forensic Medicine Osteopathic Medicine
Association between an antibiotic stewardship programme and length of stay: evidence from patients after cardiac surgery

Association between an antibiotic stewardship programme and length of stay: evidence from patients after cardiac surgery

Authors

Omar Farouk

Omar Farouk

American University of Beirut Medical Center, Jordan

Corresponding
Sarah Okafor

Sarah Okafor

King Fahad Medical City, Ireland

Published

June 12, 2026

Paper ID

PAP-000075

Status

Published

DOI

10.65712/tmj.test000333

Association between an antibiotic stewardship programme and length of stay: evidence from patients after cardiac surgery

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Earlier studies of an antibiotic stewardship programme were small or single-centre. Methods: Eligible participants were patients after cardiac surgery. Results: Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups. Conclusion: These findings suggest that an antibiotic stewardship programme is associated with better length of stay in patients after cardiac surgery.

Introduction

The cost of length of stay to health systems is substantial. Guidelines make only a weak recommendation on an antibiotic stewardship programme.

Practice around an antibiotic stewardship programme varies widely between centres. The cost of length of stay to health systems is substantial.

The cost of length of stay to health systems is substantial. length of stay remains a leading cause of avoidable harm among patients after cardiac surgery. Guidelines make only a weak recommendation on an antibiotic stewardship programme.

Materials and Methods

Eligible participants were patients after cardiac surgery. We conducted a retrospective cohort study across 3 centres between 2015 and 2023. Missing data were handled with multiple imputation.

Analyses were adjusted for age, sex and baseline severity. Missing data were handled with multiple imputation.

We conducted a retrospective cohort study across 11 centres between 2018 and 2021. The primary outcome was length of stay, assessed blind to allocation.

Results

Effects were consistent across prespecified subgroups. The adjusted odds ratio was 0.63 (95% CI 0.22 to 0.96).

GroupnEvents
Intervention56945
Centre A880101
Intervention47039
Age ≥ 6547113
Centre A4061
TABLE 1: Primary outcome by group
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Kaplan–Meier curve for length of stay
Shown for patients after cardiac surgery; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Distribution of length of stay
Shown for patients after cardiac surgery; error bars are 95% confidence intervals.

Effects were consistent across prespecified subgroups. 2726 participants were included (median age 82 years). 2922 participants were included (median age 32 years). length of stay occurred in 6% of the intervention group versus 31% of controls.

Discussion

Future work should test an antibiotic stewardship programme in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols. These findings suggest that an antibiotic stewardship programme is associated with better length of stay in patients after cardiac surgery.

These findings suggest that an antibiotic stewardship programme is associated with better length of stay in patients after cardiac surgery. Residual confounding cannot be excluded. Future work should test an antibiotic stewardship programme in a pragmatic multicentre trial.

Implementation will depend on staffing, cost and local protocols. Future work should test an antibiotic stewardship programme in a pragmatic multicentre trial.

Conclusions

An antibiotic stewardship programme may be offered for patients after cardiac surgery to improve length of stay.

References

1. Ibrahim X, Costa T, et al. Telemedicine follow-up and in-hospital mortality. Crit Care Med. 2010;214(7):874-933.

2. Yilmaz I, Ibrahim G, et al. Tranexamic acid and 30-day readmission. BMJ. 2020;294(4):628-1667.

3. Kim N, Nakamura F, et al. Telemedicine follow-up and medication adherence. Lancet. 2017;42(9):2-1013.

4. Andersen I, Ahmed W, et al. Early enteral nutrition and length of stay. Diabetes Care. 2009;129(4):314-1650.

5. Haddad W, Yilmaz A, et al. Tranexamic acid and acute kidney injury. N Engl J Med. 2015;256(5):797-1121.

Appendices

The statistical analysis plan is in the online supplement.